Nanobody-loaded nanobubbles targeting the G250 antigen with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities for specifically enhanced imaging of RCC

• Published in: Nanoscale 2023-12, Vol.16 (1), p.343-359
• Main Authors: Chen, Jiajiu, Li, Jingyi, Zhong, Chengjie, Ling, Yi, Liu, Deng, Li, Xin, Xu, Jing, Liu, Qiuli, Guo, Yanli, Wang, Luofu
• Format: Article
• Language: English
• Subjects: Antigens; Biotin; Carcinoma, Renal Cell - diagnostic imaging; Cell Line, Tumor; Diagnosis; Flow cytometry; Humans; Imaging; Immunofluorescence; Indocyanine Green; Kidney Neoplasms - diagnostic imaging; Lipids; Multimodal Imaging; Particle size; Ultrasonic imaging; Ultrasonography - methods; Zeta potential
• ISSN: 2040-3364; 2040-3372
• DOI: 10.1039/d3nr04097f

Clinicians have attempted to discover a noninvasive, easy-to-perform, and accurate method to distinguish benign and malignant renal masses. The targeted nanobubbles (NBs) we constructed that target the specific membrane antigen of renal cell carcinoma (RCC), G250, and contain indocyanine green (ICG) provide multimodal enhanced imaging capability in ultrasound/photoacoustic/fluorescence for RCC which may possibly solve this problem. In this study, we encapsulated ICG in the lipid shell of the NBs by mechanical oscillation, then anti-G250 nanobodies (AGN) were coupled to the surfaces by the biotin-streptavidin bridge method, and the nanobubble named AGN/ICG-NB was completely constructed. The average particle diameter of the prepared AGN/ICG-NBs was (427.2 ± 4.50) nm, and the zeta potential was (−13.33 ± 1.01) mV. Immunofluorescence and flow cytometry confirmed the specific binding capability of AGN/ICG-NBs to G250-positive cells. In vitro imaging experiments confirmed the multimodal imaging capability of AGN/ICG-NBs, and the in vivo imaging experiments demonstrated the specifically enhanced ability of AGN/ICG-NBs for ultrasound/photoacoustic/fluorescence imaging of human-derived RCC tumors. The biosafety of AGN/ICG-NB was verified by CCK-8 assay, organ H&E staining and blood biochemical indices. In conclusion, the targeted nanobubbles we prepared with ultrasound/photoacoustic/fluorescence multimodal imaging capabilities provide a potentially feasible approach to address the need for early diagnosis and differential diagnosis of renal masses. Clinicians have attempted to discover a noninvasive, easy-to-perform, and accurate method to distinguish benign and malignant renal masses.